Metraipolis › archive › dc_a37b8edb4e98

Dicaffeoylquinic acid alleviates alcoholic liver disease by targeting PLA2G4B and inhibiting the MAPK signaling pathway — Europe PMC PMID:42292845

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292845
DOI
10.3389/fphar.2026.1823992
License (as archived)
solo-consultazione
Archived
2026-11-01T04:07:35.688Z
SHA-256 of the archived text
03f3a4a935ca818b86c8365c3685b8b979aa88dd2d1cef99ea7da5ecaa692e37
Stable URL of this page
https://metraipolis.com/documento/dc_a37b8edb4e98

How to cite

Dicaffeoylquinic acid alleviates alcoholic liver disease by targeting PLA2G4B and inhibiting the MAPK signaling pathway — Europe PMC PMID:42292845 — Europe PMC (en), https://europepmc.org/article/MED/42292845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a37b8edb4e98 (Metraipolis archive dc_a37b8edb4e98, sha256 03f3a4a935ca818b86c8365c3685b8b979aa88dd2d1cef99ea7da5ecaa692e37)
BibTeX
@misc{dca37b8edb4e98,
  title = {Dicaffeoylquinic acid alleviates alcoholic liver disease by targeting PLA2G4B and inhibiting the MAPK signaling pathway — Europe PMC PMID:42292845},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292845},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a37b8edb4e98; sha256 03f3a4a935ca818b86c8365c3685b8b979aa88dd2d1cef99ea7da5ecaa692e37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292845. Agents can read the archived copy with the MCP tool read_document.